{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:57:39Z","timestamp":1790470659463,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["R21 AI119775-01, R43 AI119775-01, and R21 AI121550"],"award-info":[{"award-number":["R21 AI119775-01, R43 AI119775-01, and R21 AI121550"]}]},{"name":"J.C.T. laboratory","award":["RO1 AI047140, RO1 AI077719, and RO1 AI079665"],"award-info":[{"award-number":["RO1 AI047140, RO1 AI077719, and RO1 AI079665"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.virol.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,13]],"date-time":"2016-11-13T23:45:25Z","timestamp":1479080725000},"page":"35-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein"],"prefix":"10.1016","volume":"501","author":[{"given":"Benson Y.H.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Nogales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez-Sobrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2016.11.001_bib1","doi-asserted-by":"crossref","first-page":"10404","DOI":"10.1128\/JVI.00856-11","article-title":"The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain","volume":"85","author":"Albarino","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","article-title":"Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage","volume":"72","author":"Andre","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib3","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1128\/JVI.77.5.2866-2872.2003","article-title":"Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1\/S1P","volume":"77","author":"Beyer","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2016.11.001_bib5","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/v2112443","article-title":"Inhibition of the type I interferon antiviral response during arenavirus infection","volume":"2","author":"Borrow","year":"2010","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.virol.2016.11.001_bib6","doi-asserted-by":"crossref","first-page":"e1000455","DOI":"10.1371\/journal.ppat.1000455","article-title":"Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa","author":"Briese","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2016.11.001_bib7","unstructured":"Buchmeier, M.J., Peter, C.J., de la Torre, J.C., 2007. Arenaviridae: The viruses and their replication."},{"key":"10.1016\/j.virol.2016.11.001_bib8","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/JVI.80.7.3259-3272.2006","article-title":"Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region","volume":"80","author":"Burns","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib9","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1128\/JVI.00508-09","article-title":"Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons","volume":"83","author":"Burns","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib10","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.vaccine.2007.02.038","article-title":"A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity","volume":"25","author":"Carrion","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2016.11.001_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-3542(02)00202-4","article-title":"Arenaviruses other than Lassa virus","volume":"57","author":"Charrel","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2016.11.001_bib12","doi-asserted-by":"crossref","DOI":"10.3791\/50662-v","article-title":"Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells","author":"Cheng","year":"2013","journal-title":"J. Vis. Exp.: JoVE"},{"key":"10.1016\/j.virol.2016.11.001_bib13","doi-asserted-by":"crossref","first-page":"7373","DOI":"10.1128\/JVI.00307-15","article-title":"Arenavirus genome rearrangement for the development of live attenuated vaccines","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib14","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/JVI.03401-14","article-title":"Development of live-attenuated arenavirus vaccines based on codon deoptimization","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib15","article-title":"Development of live-attenuated arenavirus vaccines based on codon deoptimization","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib16","first-page":"554","article-title":"Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A\/Ann Arbor\/6\/60 (H2N2)","volume":"167","author":"Cox","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.11.001_bib17","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/JVI.02636-14","article-title":"Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine","volume":"89","author":"Cox","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2016.11.001_bib18","doi-asserted-by":"crossref","first-page":"e1000047","DOI":"10.1371\/journal.ppat.1000047","article-title":"Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia","author":"Delgado","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2016.11.001_bib19","doi-asserted-by":"crossref","first-page":"13910","DOI":"10.1073\/pnas.96.24.13910","article-title":"Mutation rates among RNA viruses","volume":"96","author":"Drake","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.11.001_bib20","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1128\/JVI.05616-11","article-title":"Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP","volume":"85","author":"Droniou-Bonzom","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib21","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0900088106","article-title":"Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest","volume":"106","author":"Emonet","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.11.001_bib22","first-page":"215","article-title":"[Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety]","volume":"70","author":"Enria","year":"2010","journal-title":"Medicina"},{"key":"10.1016\/j.virol.2016.11.001_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2016.11.001_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.coviro.2013.04.007","article-title":"Vaccines for viral hemorrhagic fevers--progress and shortcomings","volume":"3","author":"Falzarano","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib25","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa053240","article-title":"Transmission of lymphocytic choriomeningitis virus by organ transplantation","volume":"354","author":"Fischer","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2016.11.001_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/14760584.3.2.189","article-title":"Lassa fever vaccine","volume":"3","author":"Fisher-Hoch","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2016.11.001_bib27","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1073\/pnas.1113300109","article-title":"Viral reassortment as an information exchange between Viral segments","volume":"109","author":"Greenbaum","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.11.001_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon bias and heterologous protein expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.virol.2016.11.001_bib29","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1056\/NEJM199010183231607","article-title":"Lassa fever in the United States. Investigation of a case and new guidelines for management.","volume":"323","author":"Holmes","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2016.11.001_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0022-2836(82)90250-9","volume":"158","author":"Ikemura","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2016.11.001_bib31","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1086\/322620","article-title":"Viral hemorrhagic fever hazards for travelers in Africa","volume":"33","author":"Isaacson","year":"2001","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.virol.2016.11.001_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","article-title":"Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted A\/ann arbor\/6\/60","volume":"306","author":"Jin","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.11.001_bib33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0958-1669(95)80082-4","article-title":"Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli","volume":"6","author":"Kane","year":"1995","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.virol.2016.11.001_bib34","doi-asserted-by":"crossref","first-page":"e37398.","DOI":"10.1371\/journal.pone.0037398","article-title":"Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity","volume":"7","author":"Karki","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.virol.2016.11.001_bib35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clind\/24.4.718","article-title":"Treatment of Bolivian hemorrhagic fever with intravenous ribavirin","volume":"24","author":"Kilgore","year":"1997","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.virol.2016.11.001_bib36","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1160\/TH09-06-0357","article-title":"The role of the vascular endothelium in arenavirus haemorrhagic fevers","volume":"102","author":"Kunz","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.virol.2016.11.001_bib37","doi-asserted-by":"crossref","first-page":"13169","DOI":"10.1073\/pnas.1411290111","article-title":"Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization","volume":"111","author":"Le Nouen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.11.001_bib38","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/JVI.74.8.3470-3477.2000","article-title":"NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib39","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3390\/v4112514","article-title":"Advanced vaccine candidates for Lassa fever","volume":"4","author":"Lukashevich","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2016.11.001_bib40","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib41","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","article-title":"Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates","volume":"26","author":"Lukashevich","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2016.11.001_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/514211","article-title":"Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group","volume":"177","author":"Maiztegui","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2016.11.001_bib43","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1128\/JVI.00555-06","article-title":"Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus","volume":"80","author":"Martinez-Sobrido","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib44","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.1128\/JVI.00882-07","article-title":"Differential inhibition of type I interferon induction by arenavirus nucleoproteins","volume":"81","author":"Martinez-Sobrido","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib45","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1128\/JVI.00763-09","article-title":"Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus","volume":"83","author":"Martinez-Sobrido","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib46","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2016.11.001_bib47","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.32.9.1304","article-title":"Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever","volume":"32","author":"McKee","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2016.11.001_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000150276","article-title":"Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques","volume":"34","author":"McKee","year":"1992","journal-title":"Intervirology"},{"key":"10.1016\/j.virol.2016.11.001_bib49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nbt.1636","article-title":"Live attenuated influenza virus vaccines by computer-aided rational design","volume":"28","author":"Mueller","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2016.11.001_bib50","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1128\/JVI.00738-06","article-title":"Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity","volume":"80","author":"Mueller","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/nar\/24.1.214","article-title":"Codon usage tabulated from the international DNA sequence databases","volume":"24","author":"Nakamura","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2016.11.001_bib52","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1128\/JVI.01565-14","article-title":"Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development","volume":"88","author":"Nogales","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib53","doi-asserted-by":"crossref","first-page":"e1003212","DOI":"10.1371\/journal.ppat.1003212","article-title":"Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials","volume":"9","author":"Olschlager","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2016.11.001_bib54","doi-asserted-by":"crossref","first-page":"13038","DOI":"10.1128\/JVI.05834-11","article-title":"The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response","volume":"85","author":"Ortiz-Riano","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib55","first-page":"2137","article-title":"D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA","volume":"4","author":"Ortiz-Riano","year":"2012","journal-title":"Synth. Virus."},{"key":"10.1016\/j.virol.2016.11.001_bib56","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/JVI.05503-11","article-title":"Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function","volume":"86","author":"Ortiz-Riano","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib57","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1099\/vir.0.051102-0","article-title":"Arenavirus reverse genetics for vaccine development","volume":"94","author":"Ortiz-Riano","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib58","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa073785","article-title":"A new arenavirus in a cluster of fatal transplant-associated diseases","volume":"358","author":"Palacios","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2016.11.001_bib59","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1128\/JVI.01782-10","article-title":"Role of the host cell's unfolded protein response in arenavirus infection","volume":"85","author":"Pasqual","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib60","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1073\/pnas.2133782100","article-title":"The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies","volume":"100","author":"Perez","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.11.001_bib61","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.1332709100","article-title":"Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein","volume":"100","author":"Pinschewer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.11.001_bib62","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1128\/JVI.00486-11","article-title":"Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest","volume":"85","author":"Popkin","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib63","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1128\/JVI.00187-12","article-title":"Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon","volume":"86","author":"Pythoud","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib64","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1128\/JVI.00610-15","article-title":"Lymphocytic Choriomeningitis virus differentially affects the virus-induced type i interferon response and mitochondrial apoptosis mediated by RIG-I\/MAVS","volume":"89","author":"Pythoud","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib65","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1128\/JVI.78.17.9174-9189.2004","article-title":"Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization","volume":"78","author":"Ramakrishna","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib66","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02229-10","article-title":"Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses","volume":"85","author":"Rodrigo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib67","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1128\/JVI.07240-11","article-title":"Arenavirus nucleoproteins prevent activation of nuclear factor kappa B","volume":"86","author":"Rodrigo","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib68","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1462-5822.2007.01113.x","article-title":"Cell entry by human pathogenic arenaviruses","volume":"10","author":"Rojek","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.virol.2016.11.001_bib69","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/JVI.01331-07","article-title":"Cellular entry of lymphocytic choriomeningitis virus","volume":"82","author":"Rojek","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib70","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/ajt.12802","article-title":"Notes from the field: a cluster of lymphocytic choriomeningitis virus infections transmitted through organ transplantation-Iowa, 2013","volume":"14","author":"Schafer","year":"2014","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.virol.2016.11.001_bib71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/bp950056a","article-title":"Problems of translating heterologous genes in expression systems: the role of tRNA","volume":"12","author":"Smith","year":"1996","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.virol.2016.11.001_bib72","first-page":"432","article-title":"Ribavirin therapy for lassa fever","volume":"232","author":"Snell","year":"1988","journal-title":"Practitioner"},{"key":"10.1016\/j.virol.2016.11.001_bib73","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/jvi.62.2.488-495.1988","article-title":"Four viral genes independently contribute to attenuation of live influenza A\/Ann Arbor\/6\/60 (H2N2) cold-adapted reassortant virus vaccines","volume":"62","author":"Snyder","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib74","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1128\/JVI.77.19.10700-10705.2003","article-title":"Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]","volume":"77","author":"Strecker","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib75","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.vaccine.2010.02.090","article-title":"Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice","volume":"28","author":"Tenbusch","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2016.11.001_bib76","doi-asserted-by":"crossref","first-page":"e04531","DOI":"10.7554\/eLife.04531","article-title":"RNA virus attenuation by codon pair deoptimisation is an artefact of increases in CpG\/UpA dinucleotide frequencies","volume":"3","author":"Tulloch","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.virol.2016.11.001_bib77","doi-asserted-by":"crossref","first-page":"180326","DOI":"10.1155\/2011\/180326","article-title":"arenavirus budding","volume":"2011","author":"Urata","year":"2011","journal-title":"Adv. Virol."},{"key":"10.1016\/j.virol.2016.11.001_bib78","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/IAI.71.9.4961-4969.2003","article-title":"Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems","volume":"71","author":"Yadava","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2016.11.001_bib79","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1073\/pnas.1307473110","article-title":"Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.11.001_bib80","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.73.6.4972-4982.1999","article-title":"Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability","volume":"73","author":"Zhou","year":"1999","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221630349X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221630349X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:38:34Z","timestamp":1758587914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268221630349X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":80,"alternative-id":["S004268221630349X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2016.11.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}